跳至主要内容
临床试验/NCT05378438
NCT05378438Unknown不适用

Impact of Microbe Literacy Initiative on Improved Vaccine Uptake in Peri-urban Slum Areas in Kathmandu, Nepal: A Community Based Cluster Randomized Controlled Trial

Nepal Health Research Council2 个研究点 分布在 1 个国家目标入组 1,252 人开始时间: 2022年7月15日最近更新:
适应症

试验速览

阶段
不适用
入组人数
1,252
试验地点
2
主要终点
Differential vaccine acceptance rates between intervention and control group

研究概览

简要总结

This study is designed to assess the impact of the first introduction of microscope-based health education on people's attitude and practice towards disease prevention in Nepal, measured by vaccine acceptance rate. Such health education has an important role to play in communities where vaccine acceptance is low.

研究设计

研究类型
Interventional
分配方式
Randomized
干预模型
Parallel
主要目的
Health Services Research
盲法
None

入排标准

年龄范围
18 Years 至 —(Adult, Older Adult)
性别
All
接受健康志愿者

入选标准

  • People aged 18 years or older who are resident of the study target area
  • People who stayed at least for 6 months on the area of study
  • People who agrees with the procedure of study and follow ups visits
  • People who provide consent for their participation will be recruited in the study.

排除标准

  • People under 18 years of age will not be enrolled into study due to their limitation of understanding and implementation of the content of workshop given as intervention.
  • People who do not wish to participate in the trial
  • Those with currently ongoing court hearing and deprive of freedom will not be enrolled for the study.

结局指标

主要结局

Differential vaccine acceptance rates between intervention and control group

时间窗: Within 3 months of intervention

Data will be collected for baseline as well as post intervention after 3 months of workshop. For both the intervention and control group, number of vaccinated among the participants for provided COVID-19 vaccine and Typhoid vaccine will be made. Comparative analysis will be made in both the study groups before and after the intervention program.

次要结局

未报告次要终点

研究者

申办方类型
Other Gov
责任方
Principal Investigator
主要研究者

Dr. Pradip Gyanwali,MD

Executive Chief

Nepal Health Research Council

研究点 (2)

Loading locations...

相似试验